The Connected Consumer: Catch the Wave

Add this event to your calendar:
29/06/2016 17:30 29/06/2016 20:00 America/New_York The Connected Consumer: Catch the Wave Microsoft , 4th Floor Multi-purpose rooms , Cambridge , MA Johnson & Johnson Innovation, JLABS false DD/MM/YYYY

The Connected Consumer: Catch the Wave

Microsoft , 4th Floor Multi-purpose rooms , Cambridge , MA

June 29, 2016 from 17:30 PM to 20:00 PM (EST)

$10 - $35

What's powering the tide of innovation in consumer health? A generational shift toward mobile connectivity, technology advancements that allow for big data processing and analytics, and changes to healthcare models are all part of this massive shift; how does your company fit in? Are you positioned to catch the wave?

Join Johnson & Johnson Innovation for a discussion about positioning your company for innovation success. Topics include the digital trends of the connected consumer, business model considerations and scaling, as well as integrating multiple inputs in order to keep the consumer at the center of your solution.

3:30pm | Registration Open & Networking
4:00pm | Panel Discussion
5:30pm | Networking Reception
6:00pm | Program Close

Stefanie Dhanda | Sr. Director, Consumer Scientific Innovation, Johnson & Johnson Innovation read bio»
Robin Heffernan | CEO, Epidemico read bio»
Carla Small | Sr. Director of Innovation, Boston Children's Hospital read bio»
Hyuk-Jeen Suh | Head, East Coast Samsung Ventures read bio»
[moderator] Cris De Luca | Digital Health Innovation Leader, Johnson & Johnson Innovation read bio»

Who should attend:
Consumer/digital health companies and startups, entrepreneurs, advisors & investors.

$35 | General Public
$20 | Student/Academic
$45 | At the door

4th Floor Multi-purpose rooms
255 Main Street
Cambridge, MA

Speakers' Biographies:

Stefanie Dhanda | Senior Director, Consumer Scientific Innovation, Johnson & Johnson Innovation
Stefanie is Senior Director of Consumer Scientific Innovation at Johnson & Johnson Innovation, Boston. Stefanie leads Consumer sector efforts to grow and maintain a portfolio of innovative external partnerships, collaborations and investments for the benefit of J&J's Consumer businesses, which currently reach across broad and diverse sectors such as oral care, compromised skin, baby and maternal health, personal care and beauty, an OTC platform anchored in pain relief, cough/cold, and digestive health, as well as digital health platforms. Previously, Stefanie was a Managing Director at Stonebridge Associates, a Boston-based investment banking firm that she helped found in 1996. She has over 20 years of experience in providing strategic and financial advisory services to small and midsized family-owned and growth companies in the consumer and healthcare sectors. Within that role she led mergers and acquisitions engagements, raised capital, defined business and financial strategy, performed complex due diligence and negotiated strategic alliances. In addition, Stefanie was independently consulting with several innovative startup and early-stage companies focused on the nutrition, health and wellness sector. Prior to Stonebridge, she worked at the Bank of New York. Stefanie has a Bachelor of Science degree in Finance and Operations & Strategic Management from Boston College.
Connect with Stefanie:   Connect on LinkedIn

Robin Heffernan, Ph.D. | CEO, Epidemico
Robin Heffernan is a serial entrepreneur, former Venture Capitalist and strategy consultant focused on fundamentally shifting the healthcare cost curve and increasing healthcare access. Most recently, Dr. Heffernan was a Senior Associate at Flybridge Capital Partners where she drove investments in two major industries: healthcare and energy-related technologies. In addition to supporting investments in existing companies, Dr. Heffernan designed, launched and supporting early operations for two new companies: Predilytics - a healthcare analytics firm, and Sample6 - a company at the intersection of synthetic biology, data modeling and visualization. Prior to Flybridge, Dr. was a business strategy consultant for The Boston Consulting Group (BCG). While at BCG, Dr. Heffernan focused primarily in the healthcare industry, serving top tier, global pharmaceutical and biotech manufacturers as well as health care insurance payers. She engaged in a wide variety of project work including: strategic planning and corporate development, marketing and sales, and operational transformation. Dr. Heffernan completed her dissertation studies at Harvard, leading a multi-disciplinary project team, in coordination with NASA, to develop novel approaches for monitoring, predicting, and controlling global climate change. Her work included design and construction of innovative flight instruments, and also the field testing of these instruments internationally. Dr. Heffernan also earned a B.A. from Harvard in Chemistry, with highest honors.
Connect with Robin:   Connect on LinkedIn

Carla Small | Senior Director of Innovation, Boston Children's Hospital
Carla E. Small is Senior Director of Innovation at Boston Children's Hospital. Since joining Boston Children's, Carla has overseen the transition of the innovation program into the Innovation & Digital Health Accelerator (IDHA), a multi-disciplinary team that builds and scales market competitive digital health technologies. "We have sharpened our focus on accelerating and commercializing the transformative ideas of Boston Children's clinicians and researchers, but today we're also making a strategic decision to expand our reach through partnerships with industry and startups." IDHA is translating Boston Children's know-how into clinical decision support tools in partnership with Amazon, Withings, IBM Watson and GE, and is working with Rock Health to speed up the development of pediatric-focused digital health technologies. Carla joined Boston Children's in 2013, bringing extensive industry knowledge in health care, marketing, and business strategy as a consultant to start-up, mid-cap and Fortune 500 companies. She launched and ran her own health care strategy consulting firm, and before that was a consultant with Health Advances, consulting to medical device, biotechnology, pharmaceutical, diagnostic and direct-service health care providers. She also served on the Consumer Marketing Advisory Board for Medtronic Diabetes. Carla is on the School Board for Codman Academy Charter Public School in Dorchester, MA. Previously, she worked at a startup, Work/Family Directions, where she launched a series of nationwide groundbreaking work-family benefits promoting a diverse, engaged workforce. Carla received her MBA from the Harvard Business School and her undergraduate degree from Dartmouth College.
Connect with Carla:   Connect on LinkedIn

Hyuk-Jeen Suh, Ph.D., MBA | Head, Samsung Ventures East Coast
Hyuk-Jeen Suh is the Head of the Samsung Ventures East Coast office bringing over 20 years of industry experience in consumer electronics, biotech, and semiconductor. Before joining Samsung Ventures, Hyuk-Jeen worked at J.P. Morgan investment banking in the Technology, Media, and Telecom group. Prior to J.P. Morgan, he was the global senior business development and marketing manager at MEMSIC, a semiconductor startup with clients in the automobile and consumer electronics industry. He led the global marketing strategy which contributed to the successful IPO of MEMSIC in 2007. Prior to joining MEMSIC, Hyuk-Jeen was a senior research engineer at Sequenom, a biotech startup. He conducted research on DNA biochips and led joint venture projects with Hitachi and Samsung to design high-throughput bio instruments. He began his career at Intel Corporation as a process engineer, leading yield improvement projects which contributed to one of the highest yield rates in Intel history for the Pentium microprocessor. He advises startup companies and is a mentor at various startup accelerators. He is a guest speaker at universities including Harvard University, Yale University, and MIT and judges for the MIT $100K entrepreneurship competition. Hyuk-Jeen earned his Ph.D. in electrical engineering, focusing on Microelectromechanical Systems (MEMS) from University of Illinois at Urbana-Champaign. He earned his MBA from Yale School of Management. He holds a B.S. in mechanical engineering, B.A in economics and M.E in electrical engineering, all from Cornell University.
Connect with Hyuk-Jeen:   Connect on LinkedIn

[moderator] Cris De Luca, MS | Digital Health Innovation Leader, Johnson & Johnson Innovation
Cris is the Digital Health Innovation Leader at Johnson & Johnson Innovation, Boston where he is responsible for external healthcare technology innovation strategy and new ventures. Cris was previously Associate Director at Novartis Institutes for BioMedical Research where he led a Research Informatics organization building social computing and emerging technology programs. In 2010, Cris Co-Founded the largest startup venture pitch competition in the U.S. called Ultra Light Startups, accelerating hundreds of bootstrapping entrepreneurs in New England, New York, and Silicon Valley. Cris was recognized by the Boston Business Journal as a 40 Under 40 game changer and an honoree of MedTech Boston's 40 Under 40 Healthcare Innovators line-up. He holds a Bachelor of Science in Business Administration from Suffolk University and a Master of Science in Computer Information Systems from Boston University.
Connect with Cris:   Connect on LinkedIn   Connect on LinkedIn

Johnson & Johnson Innovation, JLABS

About Johnson & Johnson Innovation, JLABS Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), New York City, and with Shanghai opening in 2019. For more information please visit or follow @JLABS.

Event contact

Related content